Drug – bio-affecting and body treating compositions – Involving sex selection or contraception
Patent
1992-05-04
1994-11-08
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Involving sex selection or contraception
424851, 424856, 514 2, 514 8, 514 21, 514885, A61K 3702
Patent
active
053624890
ABSTRACT:
A purified human B-cell differentiation factor (BCDF) which does not have a natural signal peptide attached to the N-terminal thereof, DNA encoding the BCDF, transformed cells containing such DNA, a process for producing and obtaining the BCDF, compositions containing the BCDF and various therapeutic uses are disclosed.
REFERENCES:
patent: 4568640 (1986-02-01), Rubin
patent: 4730036 (1988-03-01), Ralph et al.
patent: 4782139 (1988-11-01), Di Marchi et al.
patent: 4959314 (1990-09-01), Mark et al.
Simpson et al., J. Immunol, 137, 1986, pp. 1797-1802.
Hirano et al., PNAS, 84, 1987, pp. 228-231.
Damme et al., Eur. J. Biochem 168, 1987, pp. 543-550.
Sihgal et al. Science 235, 1987, pp. 731-732.
Mirsto et al., Science 220, 1983, pp. 680-686.
Area et al., BioEssay vol. S(4) 1986, pp. 166-171.
Bealy, Bio/Technology, vol. 4(7), 1986, pp. 614-621.
Inaka et al., Trends in Biotech, 1986, pp. 68-73.
Ulmer, Science 219, 1983, pp. 666-671.
Well et al. Gene 34, 1985, pp. 315-323.
Content et al., Eur. J. Biochem. 152, 1985, pp. 253-257.
Zilberstein et al., The Interferon System, Jun. 1985, pp. 73-85.
Von Heijne, Eur J. Biochem. 133, 1983, pp. 17-21.
Davis et al., Nature 283, 1980, pp. 433-438.
Introduction to Proteins and Protein Engineering (ed Robinson, pp. 258-259, 1986.
Protein Engineering, 1986, (ed Inouje et al.) pp. 157-170.
Mary et al. Eur. J. Biochem 120, 1981, pp. 197-202.
Weissenbach et al., PNAS vol. 77, 1980, pp. 7152-7156.
"Purification to Homogeneity and Characterization of Human B-Cell Differentiation Factor (BCDF or BSF.sub.p -2)" by T. Hirano et al. Proc. Natl. Acad. Sci. USA, vol. 82, Aug. 1985; pp. 5490-5494, Washington, U.S.
"Complementary DNA for a Novel Human Interleukin (BSF-2) That Induces B Lymphocytes to Product Immunoglobulin" by T. Hirano et al.; Nature, vol. 324, 6 Nov. 1986; pp. 73-76, London, GB.
"Structural Analysis of the Sequence Coding for an Inducible 26-kDa Protein in Human Fibroblasts", by G. Haegeman et al.; European Journal of Biochemistry, vol. 159, No. 3, Sep. 1986; pp. 625-632.
Akiyama Yukio
Hirano Toshio
Kishimoto Tadamitsu
Matsui Hiroshi
Okano Akira
Ajinomoto Co. Inc.
Draper Garnette D.
Tadamitsu Kishimoto
LandOfFree
Use of recombinant B-cell differentiation factor for augmenting does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of recombinant B-cell differentiation factor for augmenting , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of recombinant B-cell differentiation factor for augmenting will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1780538